[111In-DTPA-D-Phe]-OCTREOTIDE SCINTIGRAPHY IN METASTATIC HORMONE-REFRACTORY PROSTATIC ADENOCARCINOMA WITH HIGH CHROMOGRANIN A

被引：0
|
作者：
Villa, G.
Borzone, C. [1 ]
Sambuceti, G.
Carmignani, G. [1 ]
机构：
[1] Urol Clin, Genoa, Italy
来源：
ANTICANCER RESEARCH | 2010年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
280
引用
收藏
页码：1537 / 1538
页数：2
相关论文
共 34 条
  • [21] [IN-111-DTPA-D-PHE(1)]OCTREOTIDE SCINTIGRAPHY IN THYROIDAL AND ORBITAL GRAVES-DISEASE - A PARAMETER FOR DISEASE-ACTIVITY
    POSTEMA, PTE
    KRENNING, EP
    WIJNGAARDE, R
    KOOY, PPM
    OEI, HY
    VANDENBOSCH, WA
    REUBI, JC
    WIERSINGA, WM
    HOOIJKAAS, H
    VANDERLOOS, T
    POUBLON, RML
    LAMBERTS, SWJ
    HENNEMANN, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06): : 1845 - 1851
  • [22] SOMATOSTATIN RECEPTOR SCINTIGRAPHY WITH INDIUM-111-DTPA-D-PHE-1-OCTREOTIDE IN MAN - METABOLISM, DOSIMETRY AND COMPARISON WITH IODINE-123-TYR-3-OCTREOTIDE
    KRENNING, EP
    BAKKER, WH
    KOOIJ, PPM
    BREEMAN, WAP
    OEI, HY
    DEJONG, M
    REUBI, JC
    VISSER, TJ
    BRUNS, C
    KWEKKEBOOM, DJ
    REIJS, AEM
    VANHAGEN, PM
    KOPER, JW
    LAMBERTS, SWJ
    JOURNAL OF NUCLEAR MEDICINE, 1992, 33 (05) : 652 - 658
  • [23] Somatostatin Receptor Scintigraphy with Indium-111-DTPA-D-Phe-l-Octreotide in Man: Metabolism, Dosimetry and Comparison with Iodine-123-Tyr-3-Octreotide
    Krenning, E. P.
    Bakker, W. H.
    Kooij, P. P. M.
    Breeman, W. A. P.
    Oei, H. Y.
    de Jong, M.
    Reubi, J. C.
    Visser, T. J.
    Bruns, C.
    Kwekkeboom, D. J.
    Reijs, A. E. M.
    van Hagen, P. M.
    Koper, J. W.
    Lamberts, S. W. J.
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 : 123S - 129S
  • [24] Our experience of therapy with high dose In111-DTPA-D-Phe octreotide in patients with neuroendocrine tumors.
    Trivizaki, E. M.
    Moshogiannis, B. G.
    Saranti, S. P.
    Iordanidou, L. A.
    Pateniotis, K. M.
    Matselas, E. S.
    Georgakopoulos, A. T.
    Koutsiouba, P. T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S326 - S326
  • [25] Expression of high molecular weight cytokeratin-A novel feature of aggressive and innate hormone-refractory prostatic adenocarcinoma
    Lu, Jiajie G.
    Lo, Emily T.
    Williams, Cleandrea
    Ma, Brian
    Sherrod, Andy E.
    Xiao, Guang-Qian
    PROSTATE, 2023, 83 (05): : 462 - 469
  • [26] Treatment with high dose [111In-DTPA-D-PHE1]-octreotide in patients with neuroendocrine tumors -: Evaluation of therapeutic and toxic effects
    Janson, ET
    Eriksson, B
    Öberg, K
    Skogseid, B
    Öhrvall, U
    Nilsson, S
    Westlin, JE
    ACTA ONCOLOGICA, 1999, 38 (03) : 373 - 377
  • [27] Treatment with high dose [111In-DTPA-D-PHE1]-octreotide in patients with neuroendocrine tumors - evaluation of therapeutic and toxic effects
    Janson, Eva Tiensuu
    Eriksson, Barbro
    Oberg, Kjell
    Skogseid, Britt
    Ohrvall, Ulf
    Nilsson, Sten
    Westlin, Jan-Erik
    Acta Oncologica, 38 (03): : 373 - 377
  • [28] SOMATOSTATIN RECEPTOR SCINTIGRAPHY WITH [IN-111-DTPA-D-PHE(1)]- AND [I-123-TYR(3)]-OCTREOTIDE - THE ROTTERDAM EXPERIENCE WITH MORE THAN 1000 PATIENTS
    KRENNING, EP
    KWEKKEBOOM, DJ
    BAKKER, WH
    BREEMAN, WAP
    KOOIJ, PPM
    OEI, HY
    VANHAGEN, M
    POSTEMA, PTE
    DEJONG, M
    REUBI, JC
    VISSER, TJ
    REIJS, AEM
    HOFLAND, LJ
    KOPER, JW
    LAMBERTS, SWJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1993, 20 (08): : 716 - 731
  • [29] Positron emission tomography (PET) with C-11-5-hydroxytryptophan (5-HTP) in patients with metastatic hormone-refractory prostatic adenocarcinoma
    Kalkner, KM
    Ginman, C
    Nilsson, S
    Bergstrom, M
    Antoni, G
    Ahlstrom, H
    Langstrom, B
    Westlin, JE
    NUCLEAR MEDICINE AND BIOLOGY, 1997, 24 (04): : 319 - 325
  • [30] Therapeutic efficacy and toxicity of 111ln-DTPA-D-Phe-Octreotide in patients with metastatic neuroendocrine gastroenteropancreatic tumors:: Preliminary results of a dose-escalation-study
    Wied, M
    Diedrich, J
    Schipper, ML
    Gotthardt, M
    Behe, M
    Höffken, HH
    Gratz, S
    Rinke, A
    Behr, TM
    Arnold, R
    GASTROENTEROLOGY, 2002, 122 (04) : A385 - A385
1234